Literature DB >> 25392123

Epithelial ovarian cancer - more data, more questions?

Stefanie Aust1, Dietmar Pils.   

Abstract

This review provides an overview of latest insights in epithelial ovarian cancer biology. The current understanding of the origin and the complex heterogeneity are depicted, followed by an introduction to the latest therapeutic approaches. The role of the tumor microenvironment, the high potential to disseminate within the peritoneal cavity, and new molecular biological findings are summarized.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25392123     DOI： 10.1007/s10354-014-0323-8

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN： 0043-5341


  49 in total

1.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum.

Authors:  Jaime Prat
Journal:  Int J Gynaecol Obstet       Date:  2013-10-22       Impact factor: 3.561

2.  Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium.

Authors:  Dietmar Pils; Anna Bachmayr-Heyda; Katharina Auer; Martin Svoboda; Veronika Auner; Gudrun Hager; Eva Obermayr; Angelika Reiner; Alexander Reinthaller; Paul Speiser; Ioana Braicu; Jalid Sehouli; Sandrina Lambrechts; Ignace Vergote; Sven Mahner; Astrid Berger; Dan Cacsire Castillo-Tong; Robert Zeillinger
Journal:  Eur J Cancer       Date:  2013-10-28       Impact factor: 9.162

Review 3.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

4.  A phase 3 trial of bevacizumab in ovarian cancer.

Authors:  Timothy J Perren; Ann Marie Swart; Jacobus Pfisterer; Jonathan A Ledermann; Eric Pujade-Lauraine; Gunnar Kristensen; Mark S Carey; Philip Beale; Andrés Cervantes; Christian Kurzeder; Andreas du Bois; Jalid Sehouli; Rainer Kimmig; Anne Stähle; Fiona Collinson; Sharadah Essapen; Charlie Gourley; Alain Lortholary; Frédéric Selle; Mansoor R Mirza; Arto Leminen; Marie Plante; Dan Stark; Wendi Qian; Mahesh K B Parmar; Amit M Oza
Journal:  N Engl J Med       Date:  2011-12-29       Impact factor: 91.245

Review 5.  Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

Authors:  W Glenn McCluggage
Journal:  Pathology       Date:  2011-08       Impact factor: 5.306

6.  The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.

Authors:  Rafal Matkowski; Iwona Gisterek; Agnieszka Halon; Aleksandra Lacko; Krzysztof Szewczyk; Urszula Staszek; Marek Pudelko; Bartlomiej Szynglarewicz; Jolanta Szelachowska; Andrzej Zolnierek; Jan Kornafel
Journal:  Anticancer Res       Date:  2009-07       Impact factor: 2.480

7.  Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

Authors:  Qiang Gao; Shuang-Jian Qiu; Jia Fan; Jian Zhou; Xiao-Ying Wang; Yong-Sheng Xiao; Yang Xu; Yi-Wei Li; Zhao-You Tang
Journal:  J Clin Oncol       Date:  2007-06-20       Impact factor: 44.544

8.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

9.  Determination of tumor-infiltrating CD8+ lymphocytes in human ovarian cancer.

Authors:  Stefanie Aust; Anna Bachmayr-Heyda; Dietmar Pils; Lijun Zhao; Weimin Tong; Astrid Berger; Mina Fogel; Theresa Thalhammer; Jalid Sehouli; Reinhard Horvat; Robert Zeillinger; Dan C Castillo-Tong
Journal:  Int J Gynecol Pathol       Date:  2013-05       Impact factor: 2.762

10.  Ambivalent role of pFAK-Y397 in serous ovarian cancer--a study of the OVCAD consortium.

Authors:  Stefanie Aust; Katharina Auer; Anna Bachmayr-Heyda; Carsten Denkert; Jalid Sehouli; Ioana Braicu; Sven Mahner; Sandrina Lambrechts; Ignace Vergote; Christoph Grimm; Reinhard Horvat; Dan Cacsire Castillo-Tong; Robert Zeillinger; Dietmar Pils
Journal:  Mol Cancer       Date:  2014-03-21       Impact factor: 27.401
View more
  6 in total

1.  Impact of ascites volume on clinical outcomes in ovarian cancer: A cohort study.

Authors:  J Brian Szender; Tiffany Emmons; Sarah Belliotti; Danielle Dickson; Aalia Khan; Kayla Morrell; A N M Nazmul Khan; Kelly L Singel; Paul C Mayor; Kirsten B Moysich; Kunle Odunsi; Brahm H Segal; Kevin H Eng
Journal:  Gynecol Oncol       Date:  2017-06-16       Impact factor: 5.482

2.  Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer.

Authors:  Kevin H Eng; Kayla Morrell; Kristen Starbuck; Chandra Spring-Robinson; Aalia Khan; Dana Cleason; Levent Akman; Emese Zsiros; Kunle Odunsi; J Brian Szender
Journal:  Gynecol Oncol       Date:  2017-05-08       Impact factor: 5.482

3.  The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.

Authors:  Lifei Jiang; Rong Liu; Yingying Wang; Chunmiao Li; Qinghua Xi; Jianxin Zhong; Jian Liu; Shuyun Yang; Juan Wang; Menghui Huang; Chunhui Tang; Zheng Fang
Journal:  J Mol Histol       Date:  2015-05-17       Impact factor: 2.611

4.  Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages.

Authors:  Azahara Palomar Muñoz; José Manuel Cordero García; Mª Del Prado Talavera Rubio; Ana Mª García Vicente; Francisco José Pena Pardo; Germán Andrés Jiménez Londoño; Ángel Soriano Castrejón; Enrique Aranda Aguilar
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

5.  CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.

Authors:  Ying Xu; Qing Zhang; Chunying Miao; Samina Dongol; Yinuo Li; Chenjuan Jin; Ruifeng Dong; Yingwei Li; Xingsheng Yang; Beihua Kong
Journal:  Cancer Med       Date:  2018-12-18       Impact factor: 4.452

6.  High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.

Authors:  Minzhi Hou; Zhiqiang Cheng; Hongwei Shen; Shanyang He; Yang Li; Yunping Pan; Chongjin Feng; Xinlin Chen; Yang Zhang; Millicent Lin; Liantang Wang; Zunfu Ke
Journal:  Oncotarget       Date:  2015-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.